Healthextras (NASDAQ:HLEX)
Historical Stock Chart
From Jun 2019 to Jun 2024
HealthExtras, Inc. (NASDAQ:HLEX) announced that it will change its name
to Catalyst Health Solutions, Inc. after a unanimous vote by the board
of directors on September 10, 2008. The change will become effective on
October 1, 2008 and the Company will trade under the ticker symbol “CHSI”.
“As our largest operating subsidiary, Catalyst
Rx has significant brand recognition among our clients,”
said David T. Blair, Chief Executive Officer of Catalyst Health
Solutions. “Aligning the corporate brand with
our most visible operation capitalizes on Catalyst Rx’s
brand equity and creates consistency for our shareholders and clients.”
Catalyst Rx accounted for substantially all of the total corporate
revenue for the year ended December 31, 2007, and provides integrated
pharmacy benefit management services for more than 5 million members in
the United States and Puerto Rico.
The day-to-day operations of the Company will remain unchanged.
About HealthExtras, Inc. (soon to become Catalyst Health Solutions,
Inc.)
HealthExtras Inc. is built on strong, innovative principles in the
management of prescription drug benefits and provides an unbiased,
client-centered philosophy resulting in a year-over-year client
retention rate of more than 98%. The Company’s
subsidiaries include Catalyst Rx, a full-service pharmacy benefit
manager serving more than five million lives in the United States and
Puerto Rico; HospiScript Services, LLC, one of the largest providers of
pharmacy benefit management services to the hospice industry; and
Immediate Pharmaceutical Services, Inc., a fully-integrated prescription
mail service facility based out of Avon Lake, Ohio. The Company’s
clients include self-insured employers including state and local
governments, managed care organizations, unions, hospices, third-party
administrators and individuals.
This press release may contain forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934. These
forward-looking statements involve a number of risks and uncertainties.
Factors that we have identified that might materially affect our results
are discussed in our Annual Report on Form 10-K for the year ended
December 31, 2007 under "Item 1.A Risk Factors." Readers are urged to
carefully review and consider the various disclosures made in our Annual
Report on Form 10-K and our other filings with the Securities and
Exchange Commission that attempt to advise interested parties of the
risks and uncertainties that may affect our business.